See the DrugPatentWatch profile for Leucovorin
Leucovorin, also known as Wellcovorin, is used in chemotherapy regimens to lessen the toxicity of the drug methotrexate [1]. It works by overriding the antifolic acid effects of methotrexate, allowing for the rescue of healthy cells [1][2]. This rescue is crucial in preventing serious side effects from methotrexate treatment [2].
How does Leucovorin help in cancer treatment?
Leucovorin is administered after high doses of methotrexate to counteract its effects [1][2]. Methotrexate inhibits dihydrofolate reductase, an enzyme essential for DNA synthesis and cell replication in both cancerous and healthy cells. By providing leucovorin, which is a reduced form of folic acid, the folate pathway is replenished, rescuing normal cells from the damaging effects of methotrexate while leaving cancer cells, which are more dependent on the folate pathway, vulnerable to the drug's action [1][2].
What conditions is Leucovorin prescribed for?
Beyond its role in methotrexate rescue, leucovorin is also used in combination with other chemotherapy drugs, such as fluorouracil (5-FU), to enhance the anti-cancer effects of 5-FU in treating colorectal cancer [1][3]. It works by stabilizing the binding of 5-FU to thymidylate synthase, an enzyme crucial for DNA synthesis, thereby increasing the drug's effectiveness [3].
What are the potential side effects of Leucovorin?
While leucovorin is generally well-tolerated, some individuals may experience side effects. These can include allergic reactions such as itching, rash, hives, and difficulty breathing. Gastrointestinal issues like nausea and vomiting have also been reported [1].
How is Leucovorin administered?
Leucovorin is typically administered intravenously (IV) or intramuscularly (IM) [1]. The specific dosage and schedule depend on the chemotherapy regimen and the patient's individual response [2].
What is the typical duration of Leucovorin treatment?
The duration of leucovorin treatment is dependent on the chemotherapy protocol it is part of. In methotrexate rescue therapy, it is administered over a period following the high-dose methotrexate infusion, with the exact duration determined by methotrexate blood levels and the patient's renal function [2]. When used in combination with 5-FU for colorectal cancer, it is administered on specific days within the chemotherapy cycle [3].
Are there alternatives to Leucovorin for methotrexate rescue?
While leucovorin is the standard for methotrexate rescue, its primary function is to replenish folates. In essence, any method of providing reduced folates could theoretically serve a similar rescue purpose, but leucovorin is the established and clinically validated agent [1][2].
What is the mechanism of action of Leucovorin?
Leucovorin is a reduced form of folic acid. It bypasses the enzymatic step inhibited by methotrexate (dihydrofolate reductase) and directly enters the folate metabolic pathway, enabling the synthesis of thymidylate and purines, which are essential for DNA synthesis and cell repair. This allows normal cells to recover from the effects of methotrexate [1][2].
Where can I find more information on drug patents related to Leucovorin?
Information regarding drug patents, including those related to leucovorin and its applications, can be found on DrugPatentWatch.com [4].
Sources:
[1] https://www.cancer.gov/about-cancer/treatment/drugs/leucovorin
[2] https://www.ncbi.nlm.nih.gov/books/NBK557730/
[3] https://www.cancer.gov/about-cancer/treatment/drugs/fluorouracil
[4] https://drugpatentwatch.com/